Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 38 (2), 144-153
- https://doi.org/10.1080/07853890500422982
Abstract
AIM. As the capability of human mesenchymal stem cells (hMSC) to engraft, differentiate and improve myocardial function cannot be studied in humans, exploration was performed in a xenomodel. METHODS. The rats were divided into three groups depending on the type of rats used (Rowett nude (RNU) or Fischer rats +/− immunosuppression). Different groups were treated with intramyocardial injection of hMSC (1–2 million) either directly or three days after ligation of the left anterior descending artery (LAD). Myocardial function was investigated by echocardiography. The hMSC were identified with fluorescence in situ hybridization and myocardial differentiation was assessed by immunohistochemistry. RESULTS. When hMSC were injected directly after LAD ligation they could be identified in half (8/16) of the RNU rats (without immunosuppression) at 4 weeks. When injected 3 days after LAD ligation in immunosuppressed RNU rats they were identified in all (6/6) rats at 6 weeks. The surviving hMSC showed signs of differentiation into fibroblasts. No cardiomyocyte differentiation was observed. There was no difference in myocardial function in treated animals compared to controls. CONCLUSIONS. The hMSC survived in this xenomodel up to 6 weeks. However, hMSC required implantation into immunoincompetent animals as well as immunosuppression to survive, indicating that these cells are otherwise rejected. Furthermore, these cells did not differentiate into cardiomyocytes nor did they improve heart function in this xenomodel.Keywords
This publication has 28 references indexed in Scilit:
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppressionJournal of Biomedical Science, 2005
- Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardiumThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarctsNature, 2004
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsExperimental Hematology, 2003
- Animal models in xenotransplantationExpert Opinion on Investigational Drugs, 2000
- Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular functionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and managementThe American Journal of Cardiology, 1991